You are here

A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Den Haag, , 2501 CK Netherlands
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Sleep Deprivation, Partial Epilepsies
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Partial epileptic seizures

- Not taking more than 1 background antiepileptic drug at study entry

- Disturbed sleep

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- More than 1 secondarily generalized tonic/clonic seizure per week on average over the
previous 3 months

- Medical, psychological, or social conditions that could interfere with normal sleep

NCT00643136
Pfizer
Completed
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Partial Epilepsies
NCT00351611
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now